Identifying potential inhibitors for wild-type EGFR tyrosine kinase through a cross-talk pathway strategy and an in-silico drug repurposing method - Dorra Abdelmalek; Kawther Bedchich; Fahmi Smaoui; Salim Kraiem; Mohamed Ali Mosrati; Mohamed Sami Aifa (PLoS ONE, 2026)